Navigation Links
Investor Relations Firm Access IR/PR and The Communications Strategy Group Announce Strategic Alliance
Date:10/29/2009

Access IR/PR, a San Diego-based investor and public relations firm, and The Communications Strategy Group Inc. (CSG), a corporate/financial communications consultancy based in Boston, have formed a strategic alliance. The alliance expands the senior-level talent and services available to both firms' clients and provides extended access to key financial, investor and media communities in the U.S. and abroad as well as assistance with capital formation, joint ventures and corporate partnering.

San Diego, CA, and Boston, MA (PRWEB) October 29, 2009 -- Access IR/PR, a San Diego-based investor and public relations firm, and The Communications Strategy Group Inc. (CSG), a corporate/financial communications consultancy based in Boston, have formed a strategic alliance. The alliance expands the senior-level talent and services available to both firms' clients and provides extended access to key financial, investor and media communities in the U.S. and abroad as well as assistance with capital formation, joint ventures and corporate partnering.

Access IR/PR
Access IR/PR provides strategic, senior-level investor relations and corporate communications counsel and support to public and private companies in the biotechnology, medical device and emerging technology industries. The firm is led by Scott A. Rieger, who previously served as Vice President, Corporate Communications and Investor Relations at Hollis-Eden Pharmaceuticals (NASDAQ: HEPH), and Andrew Wiseman, Ph.D., formerly Senior Director of Investor Relations at La Jolla Pharmaceutical Company (NASDAQ: LJPC).

Access IR/PR's services include counsel on corporate message development; drafting and production of communications tools and materials; execution of targeted investor, media, key opinion leader and industry outreach programs; development and execution of appropriate internal systems, policies and procedures; and training an
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Cell Therapeutics, Inc.s (CTI) Presentation at BIO Investor Forum to be Webcast
2. Soligenix to Present at 8th Annual BIO Investor Forum
3. Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2009
4. AEterna Zentaris Receives US$5.5 Million from Institutional Investors
5. Epeius Biotechnologies to Partner at BIO Investor Forum
6. Transdel Pharmaceuticals to Present at Two Investor Conferences
7. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 2009 BIOCOM INVESTOR CONFERENCE
8. AEterna Zentaris to Raise US$5.5 Million from Institutional Investors at US$1.20 Per Share
9. Advanced Life Sciences to Present at 8th Annual BIO Investor Forum
10. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO
11. New Oxygen Biotherapeutics, Inc. Investor Presentation Available on Company Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... GEA Niro Soavi the leader in high ... PandaPLUS 2000, which is ideal for new applications for ... disruption . This compact laboratory homogenizer is the perfect ... food additives and ingredients as well as for the ...
(Date:1/22/2015)... Protocol Networks brings independent technology consulting to the ... consultants, Protocol Networks has recently announced its expansion into ... his company has attracted several clients in The Constitution ... as others. With the success of these engagements, Rogers ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was invited to ... on probiotics in San Diego, CA. , The Scripps ... health care professionals. This year’s pre-conference seminar was held on ... Dr. Leyer spoke about the emerging topics and science in ...
(Date:1/22/2015)... Nueva Jersey , 22 de enero de 2015 ... Research abre hoy su llamada a nominaciones para 2015. ... científica ha hecho, o tiene el potencial para hacer, ... Las nominaciones se aceptarán hasta el 15 de marzo ...
Breaking Biology Technology:GEA Niro Soavi Announces the PandaPLUS 2000 Homogenizer for Processing New Applications for Nanoemulsions and Cell Disruption 2Protocol Networks Brings Independent Technology Consulting to the Constitution State 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4
... information security firm Symantec released the 11th edition ... Symantec's attempt to get out of the day-to-day and see ... ominous, according to Dave Cole, a director in the Symantec ... game today is data theft, and the creation of malicious ...
... the growing dependence on transportation infrastructure between Illinois ... connect new and existing developments was highlighted. Building ... having a great supporting infrastructure, but I was ... reader Larry Zielonka, a CPA, commented that the ...
... reported net income of $113.5 million during the first ... revenues rising 11 percent over the same quarter in 2006. ... services industry, said net income was down from the $116.2 ... per share were slightly higher than the $0.64 in the ...
Cached Biology Technology:Symantec: Cyber fraudsters look for low-hanging fruit 2Symantec: Cyber fraudsters look for low-hanging fruit 3Symantec: Cyber fraudsters look for low-hanging fruit 4Symantec: Cyber fraudsters look for low-hanging fruit 5Symantec: Cyber fraudsters look for low-hanging fruit 6Symantec: Cyber fraudsters look for low-hanging fruit 7Mega-Metro Center may go beyond Chicago and Wisconsin 2Mega-Metro Center may go beyond Chicago and Wisconsin 3Mega-Metro Center may go beyond Chicago and Wisconsin 4Mega-Metro Center may go beyond Chicago and Wisconsin 5
(Date:1/22/2015)... Issued by Small Cap IR. In 2011, Nilson Report,s annual ... merchants on the leading payment cards rose to $135.3 billion ... prepaid cards reached 6.54 billion.  Eight million credit card users ... 2012, and credit and debit card fraud resulted in $11.27 ...
(Date:1/22/2015)... has launched its new NXG series of time clocks with ... higher standard for collecting attendance and labor data and complements ... touch screen interface and seamless connection to cloud-based iSolved, the ... for the small to mid-size employer. The G2 ...
(Date:12/22/2014)... 22, 2014  The 2014 Holiday Season may be the ... Intelligence reports that the long anticipated floodgates for consumer ... demand for smart phones, tablets, and wearable mobile devices ... 2.5 billion users with nearly 4.8 billion biometric devices ...
Breaking Biology News(10 mins):$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2Infinisource's NXG series sets new time clock standard 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2
... discovered how a network of repair proteins enables bacteria to ... the DNA molecules that carry the instructions necessary for living ... at the University of Bristol and published in Molecular ... between the DNA repair systems of bacteria and humans than ...
... 38 million people worldwide are currently infected with HIV ... For scientists to design treatment therapies that are effective ... about how the virus mutates and develops resistance to ... biomedical engineer Stephanie Willerth has significantly advanced the understanding ...
... Researchers presented Phase III efficacy data from the GeparQuinto ... in combination with chemotherapy for patients with early breast ... Cancer Symposium, held Dec. 8-12. "We had ... combination of chemotherapy, trastuzumab, with the new combination of ...
Cached Biology News:New research reveals details of microbe's extraordinary maintenance and repair system 2UVic biomedical engineer 'outsmarts' HIV 2Phase III study compared neoadjuvant therapy with lapatinib or trastuzumab for early breast cancer 2